Top Section/Ad
Top Section/Ad
Most recent
DocMorris announces Sfr200m rights issue expected in May
Stock drops 17% in highly volatile market
Deal follows steep share price fall
More articles/Ad
More articles/Ad
More articles
-
Shanghai Junshi Biosciences has raised HK$2.56bn ($330.5m) in equity capital from a placement of shares that drew a solid response from investors both during wall-crossing and bookbuilding. -
There was little let-up in demand for property companies' bonds on Tuesday, as investors stocked up on Inmobilaria Colonial and debut issuer Sirius Real Estate, before the void of issuance expected from the tail end of this week.
-
Europe’s equity capital markets bankers are expressing concern that deals they’re working on now will be damaged if the re-opening of the continent’s economies is reversed in the autumn. But new research on Covid-19 and last year’s pattern of infections shows they’re right to be nervous.
-
LinkDoc Technology, a cancer-focused medical data company, has filed paperwork for a $100m offering of American depository shares (ADS).
-
A group of Suriname’s bondholders on Monday followed through on their threat to cancel the payment relief that they had offered the sovereign, effectively pushing the government into technical default. But the move only supports expectations that restructuring negotiations will be lengthy and fraught.
-
Two European animal healthcare companies have announced their intention to float in recent days. Bankers hope that the fast growing sector will offer something different in a crowded pipeline of new stockmarket listings in the region.
